CS logo
small CS logo
Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore

Milano, Italy
Hospital in Milan
Via Francesco Sforza, 35, 20122 Milano MI
900 Beds

About Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore


The Policlinico of Milan also known as Ospedale Maggiore di Milano or Ca' Granda Ospedale Maggiore Policlinico, is one of the oldest hospitals in Italy, founded by Duke Francesco Sforza in 1456. Today it is a modern hospital with 900 beds, with wards for adults, pregnant women and children.
There are 900 beds in Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore


During the past decade, Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore


According to Clinical.Site data, the most researched conditions in "Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore" are "End Stage Renal Disease" (2 trials), "Atypical Hemolytic Uremic Syndrome" (1 trials), "Chronic Renal Anemia" (1 trials), "Diabetes" (1 trials) and "Insulin Resistance" (1 trials). Many other conditions were trialed in "Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore" in a lesser frequency.

Clinical Trials Intervention Types at Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore


Most popular intervention types in "Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Crovalimab" (1 trials), "Darbepoetin Alfa" (1 trials), "Epoetin Alfa" (1 trials), "Epoetin Beta" (1 trials) and "PD Solution" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore


The vast majority of trials in "Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore" are 4 trials for "All" genders.

Clinical Trials Status at Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore


Currently, there are NaN active trials in "Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".